Synthesis and biological evaluation of benzimidazole-4,7-diones that inhibit vascular smooth muscle cell proliferation

Bioorg Med Chem Lett. 2004 Jul 5;14(13):3563-6. doi: 10.1016/j.bmcl.2004.04.051.

Abstract

A series of 6-arylamino-5-chloro-benzimidazole-4,7-diones were synthesized and tested for their inhibitory activity on the rat aortic smooth muscle cell (RAoSMC) proliferation. Among them, 6-arylamino-5-chloro-2-methyl-benzimidazole-4,7-diones exhibited potent antiproliferative activity. Benzimidazole-4,7-dione 2c activated SAPK/JNK signaling pathway in the RAoSMCs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benzimidazoles / chemical synthesis*
  • Benzimidazoles / pharmacology
  • Cell Division / drug effects*
  • Cells, Cultured
  • Growth Inhibitors / chemical synthesis*
  • Growth Inhibitors / metabolism
  • Growth Inhibitors / pharmacology
  • Inhibitory Concentration 50
  • JNK Mitogen-Activated Protein Kinases / metabolism
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / drug effects*
  • Muscle, Smooth, Vascular / metabolism
  • Platelet-Derived Growth Factor / metabolism
  • Rats
  • Signal Transduction / drug effects

Substances

  • Benzimidazoles
  • Growth Inhibitors
  • Platelet-Derived Growth Factor
  • JNK Mitogen-Activated Protein Kinases